The Blood & Marrow Transplant program recently received approval of a certificate of need from the state
Miami Cancer Institute, part of Baptist Health South Florida, is offering autologous stem cell transplants for patients with multiple myeloma and lymphoma on an outpatient basis, a procedure that spares patients weeks of hospitalization, often in isolation, and promotes recovery. The Institute also began performing inpatient autologous transplants for more complex cases in November of this year at Miami Cancer Institute.
“Being at home with loved ones and staying active can lead to better outcomes in certain patients,” said Guenther Koehne, M.D., Ph.D., an internationally renowned blood cancer expert and Miami Cancer Institute’s chief of Blood & Marrow Transplantation and Hematologic Oncology.
Under Dr. Koehne’s direction, the Institute already has performed several outpatient and inpatient autologous stem cell transplants for patients with multiple myeloma, Non-Hodgkin’s lymphoma and Hodgkin’s disease, in which the patient’s own stem cells are collected and then reintroduced. Allogeneic transplants, which use stem cells from a donor, are indicated for patients with leukemia, myelodysplastic and myeloproliferative disorders and are more complex procedures which always require hospitalization. These procedures will be performed at Miami Cancer Institute starting February of 2019 upon completion of a new state-of-the-art stem cell processing and immunotherapy laboratory.
Miami Cancer Institute’s Blood and Marrow Transplant program recently received approval of a certificate of need from the state’s Agency for Health Care Administration. The program expands inpatient stem cell transplant options in South Florida for patients with leukemia, non-Hodgkin’s lymphoma, multiple myeloma and other blood cancers.
“The outpatient and inpatient transplant programs are an important part of our mission to provide sophisticated, high-quality cancer care here in our region and also for those coming from the Caribbean, Latin America and beyond,” said Dr. Koehne, who has extensive experience with such procedures from his long tenure at Memorial Sloan Kettering Cancer Center in New York, where he served as one of the leading physicians in the Adult Bone Marrow Transplantation Service in the Division of Hematologic Oncology prior to joining Miami Cancer Institute.
For the outpatient transplants, stem cells are painlessly collected from the patient’s blood over several days and then frozen. The patient receives a high dose of chemotherapy a few days before the stem cells are thawed and re-infused. For about three weeks after the transplant, patients come to the Institute every day to have their blood monitored. They must live or stay within 45 minutes of Miami Cancer Institute to qualify for the outpatient procedure.
“Uniformly requiring hospitalization for an autologous stem cell transplant no longer benefits the patient, hospital or community,” added Dr. Koehne. “This procedure is very well-tolerated.”
About Miami Cancer Institute
Miami Cancer Institute is a next-generation cancer treatment destination known for its leading clinical care and research, compassionate patient experience and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean, and the only radiation oncology program in the world with each of the latest radiation therapies in one place. The Institute offers an impressive roster of established community oncologists and renowned cancer experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. As Florida’s only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments right here at home and ensures that the standards of care developed by our multidisciplinary disease management teams match those at MSK. Heralded nationally as one of the “hybrid” cancer centers of the future, Miami Cancer Institute combines high-quality community-based cancer care with the best of an academic cancer center, including innovative clinical trials tied to research and genomics and disease-specific surgeons, medical oncologists and radiation oncologists who are experts in their fields. For more information, visit MiamiCancerInstitute.com.
